nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2C19—Rosuvastatin—atherosclerosis	0.108	0.195	CbGbCtD
Bromazepam—CYP2C19—Simvastatin—atherosclerosis	0.1	0.181	CbGbCtD
Bromazepam—CYP2C19—Lovastatin—atherosclerosis	0.0982	0.177	CbGbCtD
Bromazepam—CYP3A4—Ezetimibe—atherosclerosis	0.0522	0.0942	CbGbCtD
Bromazepam—CYP3A4—Rosuvastatin—atherosclerosis	0.0522	0.0942	CbGbCtD
Bromazepam—CYP3A4—Simvastatin—atherosclerosis	0.0485	0.0875	CbGbCtD
Bromazepam—CYP3A4—Pravastatin—atherosclerosis	0.0475	0.0857	CbGbCtD
Bromazepam—CYP3A4—Lovastatin—atherosclerosis	0.0475	0.0857	CbGbCtD
Bromazepam—Nightmare—Rosuvastatin—atherosclerosis	0.00729	0.0245	CcSEcCtD
Bromazepam—Sleep disorder—Rosuvastatin—atherosclerosis	0.00633	0.0212	CcSEcCtD
Bromazepam—Nightmare—Simvastatin—atherosclerosis	0.00578	0.0194	CcSEcCtD
Bromazepam—Nightmare—Pravastatin—atherosclerosis	0.00523	0.0175	CcSEcCtD
Bromazepam—Sleep disorder—Simvastatin—atherosclerosis	0.00502	0.0168	CcSEcCtD
Bromazepam—Muscular weakness—Rosuvastatin—atherosclerosis	0.00484	0.0162	CcSEcCtD
Bromazepam—Sleep disorder—Pravastatin—atherosclerosis	0.00454	0.0152	CcSEcCtD
Bromazepam—Muscular weakness—Ezetimibe—atherosclerosis	0.00402	0.0135	CcSEcCtD
Bromazepam—Diplopia—Pravastatin—atherosclerosis	0.00393	0.0132	CcSEcCtD
Bromazepam—Muscular weakness—Simvastatin—atherosclerosis	0.00383	0.0129	CcSEcCtD
Bromazepam—Muscular weakness—Niacin—atherosclerosis	0.00352	0.0118	CcSEcCtD
Bromazepam—Muscular weakness—Pravastatin—atherosclerosis	0.00347	0.0116	CcSEcCtD
Bromazepam—Mental disorder—Rosuvastatin—atherosclerosis	0.00332	0.0111	CcSEcCtD
Bromazepam—Connective tissue disorder—Ezetimibe—atherosclerosis	0.0031	0.0104	CcSEcCtD
Bromazepam—Mental disorder—Ezetimibe—atherosclerosis	0.00276	0.00926	CcSEcCtD
Bromazepam—Malnutrition—Ezetimibe—atherosclerosis	0.00274	0.0092	CcSEcCtD
Bromazepam—Confusional state—Rosuvastatin—atherosclerosis	0.00272	0.00911	CcSEcCtD
Bromazepam—Muscle spasms—Lovastatin—atherosclerosis	0.00269	0.00902	CcSEcCtD
Bromazepam—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00264	0.00886	CcSEcCtD
Bromazepam—Muscle spasms—Ezetimibe—atherosclerosis	0.00264	0.00885	CcSEcCtD
Bromazepam—Vision blurred—Lovastatin—atherosclerosis	0.00264	0.00884	CcSEcCtD
Bromazepam—Mental disorder—Simvastatin—atherosclerosis	0.00263	0.00883	CcSEcCtD
Bromazepam—Tremor—Lovastatin—atherosclerosis	0.00262	0.00879	CcSEcCtD
Bromazepam—Eye disorder—Niacin—atherosclerosis	0.00258	0.00865	CcSEcCtD
Bromazepam—Cardiac disorder—Pravastatin—atherosclerosis	0.00252	0.00846	CcSEcCtD
Bromazepam—Muscle spasms—Simvastatin—atherosclerosis	0.00252	0.00844	CcSEcCtD
Bromazepam—Vision blurred—Simvastatin—atherosclerosis	0.00247	0.00827	CcSEcCtD
Bromazepam—Tremor—Simvastatin—atherosclerosis	0.00245	0.00822	CcSEcCtD
Bromazepam—Palpitations—Ezetimibe—atherosclerosis	0.00243	0.00813	CcSEcCtD
Bromazepam—Malnutrition—Niacin—atherosclerosis	0.0024	0.00806	CcSEcCtD
Bromazepam—Dyspepsia—Rosuvastatin—atherosclerosis	0.00237	0.00795	CcSEcCtD
Bromazepam—Tension—Niacin—atherosclerosis	0.00236	0.00791	CcSEcCtD
Bromazepam—Nervousness—Niacin—atherosclerosis	0.00233	0.00783	CcSEcCtD
Bromazepam—Dry mouth—Lovastatin—atherosclerosis	0.00233	0.00781	CcSEcCtD
Bromazepam—Tension—Pravastatin—atherosclerosis	0.00232	0.00779	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00232	0.00778	CcSEcCtD
Bromazepam—Muscle spasms—Niacin—atherosclerosis	0.00231	0.00775	CcSEcCtD
Bromazepam—Confusional state—Lovastatin—atherosclerosis	0.0023	0.00772	CcSEcCtD
Bromazepam—Nervousness—Pravastatin—atherosclerosis	0.0023	0.00771	CcSEcCtD
Bromazepam—Dry mouth—Ezetimibe—atherosclerosis	0.00229	0.00766	CcSEcCtD
Bromazepam—Anaphylactic shock—Lovastatin—atherosclerosis	0.00228	0.00766	CcSEcCtD
Bromazepam—Muscle spasms—Pravastatin—atherosclerosis	0.00227	0.00763	CcSEcCtD
Bromazepam—Vision blurred—Niacin—atherosclerosis	0.00226	0.00759	CcSEcCtD
Bromazepam—Confusional state—Ezetimibe—atherosclerosis	0.00226	0.00757	CcSEcCtD
Bromazepam—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00224	0.00751	CcSEcCtD
Bromazepam—Vision blurred—Pravastatin—atherosclerosis	0.00223	0.00748	CcSEcCtD
Bromazepam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00222	0.00745	CcSEcCtD
Bromazepam—Tremor—Pravastatin—atherosclerosis	0.00222	0.00743	CcSEcCtD
Bromazepam—Nervous system disorder—Ezetimibe—atherosclerosis	0.0022	0.00736	CcSEcCtD
Bromazepam—Anorexia—Lovastatin—atherosclerosis	0.00218	0.0073	CcSEcCtD
Bromazepam—Skin disorder—Ezetimibe—atherosclerosis	0.00218	0.00729	CcSEcCtD
Bromazepam—Confusional state—Simvastatin—atherosclerosis	0.00215	0.00722	CcSEcCtD
Bromazepam—Anaphylactic shock—Simvastatin—atherosclerosis	0.00214	0.00716	CcSEcCtD
Bromazepam—Palpitations—Niacin—atherosclerosis	0.00212	0.00712	CcSEcCtD
Bromazepam—Anorexia—Simvastatin—atherosclerosis	0.00204	0.00683	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00203	0.00681	CcSEcCtD
Bromazepam—Dyspepsia—Lovastatin—atherosclerosis	0.00201	0.00674	CcSEcCtD
Bromazepam—Dry mouth—Niacin—atherosclerosis	0.002	0.00671	CcSEcCtD
Bromazepam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00199	0.00666	CcSEcCtD
Bromazepam—Decreased appetite—Lovastatin—atherosclerosis	0.00199	0.00666	CcSEcCtD
Bromazepam—Dyspepsia—Ezetimibe—atherosclerosis	0.00197	0.00661	CcSEcCtD
Bromazepam—Fatigue—Lovastatin—atherosclerosis	0.00197	0.0066	CcSEcCtD
Bromazepam—Anaphylactic shock—Niacin—atherosclerosis	0.00196	0.00658	CcSEcCtD
Bromazepam—Confusional state—Pravastatin—atherosclerosis	0.00195	0.00653	CcSEcCtD
Bromazepam—Decreased appetite—Ezetimibe—atherosclerosis	0.00195	0.00653	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00193	0.00648	CcSEcCtD
Bromazepam—Asthenia—Rosuvastatin—atherosclerosis	0.00193	0.00648	CcSEcCtD
Bromazepam—Anaphylactic shock—Pravastatin—atherosclerosis	0.00193	0.00647	CcSEcCtD
Bromazepam—Fatigue—Ezetimibe—atherosclerosis	0.00193	0.00647	CcSEcCtD
Bromazepam—Tachycardia—Niacin—atherosclerosis	0.00191	0.00642	CcSEcCtD
Bromazepam—Pruritus—Rosuvastatin—atherosclerosis	0.00191	0.00639	CcSEcCtD
Bromazepam—Skin disorder—Niacin—atherosclerosis	0.00191	0.00639	CcSEcCtD
Bromazepam—Feeling abnormal—Lovastatin—atherosclerosis	0.00188	0.00631	CcSEcCtD
Bromazepam—Dyspepsia—Simvastatin—atherosclerosis	0.00188	0.0063	CcSEcCtD
Bromazepam—Anorexia—Niacin—atherosclerosis	0.00187	0.00627	CcSEcCtD
Bromazepam—Decreased appetite—Simvastatin—atherosclerosis	0.00186	0.00623	CcSEcCtD
Bromazepam—Feeling abnormal—Ezetimibe—atherosclerosis	0.00185	0.00619	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00184	0.00618	CcSEcCtD
Bromazepam—Fatigue—Simvastatin—atherosclerosis	0.00184	0.00617	CcSEcCtD
Bromazepam—Anorexia—Pravastatin—atherosclerosis	0.00184	0.00617	CcSEcCtD
Bromazepam—Hypotension—Niacin—atherosclerosis	0.00183	0.00614	CcSEcCtD
Bromazepam—Dizziness—Rosuvastatin—atherosclerosis	0.00178	0.00597	CcSEcCtD
Bromazepam—Feeling abnormal—Simvastatin—atherosclerosis	0.00176	0.0059	CcSEcCtD
Bromazepam—Somnolence—Niacin—atherosclerosis	0.00174	0.00585	CcSEcCtD
Bromazepam—Dyspepsia—Niacin—atherosclerosis	0.00173	0.00579	CcSEcCtD
Bromazepam—Decreased appetite—Niacin—atherosclerosis	0.0017	0.00572	CcSEcCtD
Bromazepam—Dyspepsia—Pravastatin—atherosclerosis	0.0017	0.0057	CcSEcCtD
Bromazepam—Rash—Rosuvastatin—atherosclerosis	0.0017	0.0057	CcSEcCtD
Bromazepam—Dermatitis—Rosuvastatin—atherosclerosis	0.0017	0.00569	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Niacin—atherosclerosis	0.00169	0.00568	CcSEcCtD
Bromazepam—Headache—Rosuvastatin—atherosclerosis	0.00169	0.00566	CcSEcCtD
Bromazepam—Hypersensitivity—Lovastatin—atherosclerosis	0.00168	0.00564	CcSEcCtD
Bromazepam—Decreased appetite—Pravastatin—atherosclerosis	0.00168	0.00563	CcSEcCtD
Bromazepam—Fatigue—Pravastatin—atherosclerosis	0.00166	0.00558	CcSEcCtD
Bromazepam—Hypersensitivity—Ezetimibe—atherosclerosis	0.00165	0.00553	CcSEcCtD
Bromazepam—Asthenia—Lovastatin—atherosclerosis	0.00164	0.00549	CcSEcCtD
Bromazepam—Pruritus—Lovastatin—atherosclerosis	0.00162	0.00542	CcSEcCtD
Bromazepam—Asthenia—Ezetimibe—atherosclerosis	0.00161	0.00539	CcSEcCtD
Bromazepam—Nausea—Rosuvastatin—atherosclerosis	0.0016	0.00537	CcSEcCtD
Bromazepam—Feeling abnormal—Pravastatin—atherosclerosis	0.00159	0.00534	CcSEcCtD
Bromazepam—Pruritus—Ezetimibe—atherosclerosis	0.00158	0.00531	CcSEcCtD
Bromazepam—Hypersensitivity—Simvastatin—atherosclerosis	0.00157	0.00528	CcSEcCtD
Bromazepam—Asthenia—Simvastatin—atherosclerosis	0.00153	0.00514	CcSEcCtD
Bromazepam—Pruritus—Simvastatin—atherosclerosis	0.00151	0.00507	CcSEcCtD
Bromazepam—Dizziness—Lovastatin—atherosclerosis	0.00151	0.00506	CcSEcCtD
Bromazepam—Dizziness—Ezetimibe—atherosclerosis	0.00148	0.00497	CcSEcCtD
Bromazepam—Vomiting—Lovastatin—atherosclerosis	0.00145	0.00487	CcSEcCtD
Bromazepam—Hypersensitivity—Niacin—atherosclerosis	0.00145	0.00484	CcSEcCtD
Bromazepam—Rash—Lovastatin—atherosclerosis	0.00144	0.00483	CcSEcCtD
Bromazepam—Dermatitis—Lovastatin—atherosclerosis	0.00144	0.00482	CcSEcCtD
Bromazepam—Headache—Lovastatin—atherosclerosis	0.00143	0.0048	CcSEcCtD
Bromazepam—Vomiting—Ezetimibe—atherosclerosis	0.00142	0.00477	CcSEcCtD
Bromazepam—Hypersensitivity—Pravastatin—atherosclerosis	0.00142	0.00477	CcSEcCtD
Bromazepam—Dizziness—Simvastatin—atherosclerosis	0.00141	0.00474	CcSEcCtD
Bromazepam—Rash—Ezetimibe—atherosclerosis	0.00141	0.00474	CcSEcCtD
Bromazepam—Dermatitis—Ezetimibe—atherosclerosis	0.00141	0.00473	CcSEcCtD
Bromazepam—Asthenia—Niacin—atherosclerosis	0.00141	0.00472	CcSEcCtD
Bromazepam—Headache—Ezetimibe—atherosclerosis	0.0014	0.0047	CcSEcCtD
Bromazepam—Pruritus—Niacin—atherosclerosis	0.00139	0.00465	CcSEcCtD
Bromazepam—Asthenia—Pravastatin—atherosclerosis	0.00139	0.00465	CcSEcCtD
Bromazepam—Pruritus—Pravastatin—atherosclerosis	0.00137	0.00458	CcSEcCtD
Bromazepam—Vomiting—Simvastatin—atherosclerosis	0.00136	0.00455	CcSEcCtD
Bromazepam—Nausea—Lovastatin—atherosclerosis	0.00136	0.00455	CcSEcCtD
Bromazepam—Rash—Simvastatin—atherosclerosis	0.00135	0.00452	CcSEcCtD
Bromazepam—Dermatitis—Simvastatin—atherosclerosis	0.00135	0.00451	CcSEcCtD
Bromazepam—Headache—Simvastatin—atherosclerosis	0.00134	0.00449	CcSEcCtD
Bromazepam—Nausea—Ezetimibe—atherosclerosis	0.00133	0.00446	CcSEcCtD
Bromazepam—Dizziness—Niacin—atherosclerosis	0.0013	0.00435	CcSEcCtD
Bromazepam—Dizziness—Pravastatin—atherosclerosis	0.00128	0.00428	CcSEcCtD
Bromazepam—Nausea—Simvastatin—atherosclerosis	0.00127	0.00425	CcSEcCtD
Bromazepam—Vomiting—Niacin—atherosclerosis	0.00125	0.00418	CcSEcCtD
Bromazepam—Rash—Niacin—atherosclerosis	0.00124	0.00415	CcSEcCtD
Bromazepam—Dermatitis—Niacin—atherosclerosis	0.00124	0.00414	CcSEcCtD
Bromazepam—Headache—Niacin—atherosclerosis	0.00123	0.00412	CcSEcCtD
Bromazepam—Vomiting—Pravastatin—atherosclerosis	0.00123	0.00412	CcSEcCtD
Bromazepam—Rash—Pravastatin—atherosclerosis	0.00122	0.00408	CcSEcCtD
Bromazepam—Dermatitis—Pravastatin—atherosclerosis	0.00122	0.00408	CcSEcCtD
Bromazepam—Headache—Pravastatin—atherosclerosis	0.00121	0.00406	CcSEcCtD
Bromazepam—Nausea—Niacin—atherosclerosis	0.00117	0.00391	CcSEcCtD
Bromazepam—Nausea—Pravastatin—atherosclerosis	0.00115	0.00385	CcSEcCtD
Bromazepam—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.39e-05	0.000433	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.36e-05	0.000432	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	6.35e-05	0.000431	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLTP—atherosclerosis	6.32e-05	0.000429	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.27e-05	0.000426	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.13e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	6.02e-05	0.000409	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	6.02e-05	0.000409	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	6.02e-05	0.000409	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	6.02e-05	0.000409	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ALB—atherosclerosis	6.02e-05	0.000408	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.95e-05	0.000404	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ALB—atherosclerosis	5.94e-05	0.000403	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.86e-05	0.000398	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.84e-05	0.000397	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.82e-05	0.000395	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.79e-05	0.000393	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.75e-05	0.00039	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	5.7e-05	0.000387	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.65e-05	0.000384	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	5.63e-05	0.000382	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCG1—atherosclerosis	5.62e-05	0.000381	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.51e-05	0.000374	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCG8—atherosclerosis	5.48e-05	0.000372	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LTA4H—atherosclerosis	5.48e-05	0.000372	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.48e-05	0.000372	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	5.43e-05	0.000369	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.41e-05	0.000367	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.3e-05	0.00036	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FABP4—atherosclerosis	5.28e-05	0.000358	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LCAT—atherosclerosis	5.28e-05	0.000358	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	5.28e-05	0.000358	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	5.24e-05	0.000356	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOA4—atherosclerosis	5.18e-05	0.000352	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.18e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.12e-05	0.000348	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.11e-05	0.000347	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	5.09e-05	0.000346	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP7A1—atherosclerosis	5.09e-05	0.000346	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.06e-05	0.000343	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.97e-05	0.000337	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLTP—atherosclerosis	4.93e-05	0.000334	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP27A1—atherosclerosis	4.71e-05	0.00032	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.56e-05	0.00031	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.56e-05	0.000309	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.54e-05	0.000308	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.51e-05	0.000306	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOA2—atherosclerosis	4.46e-05	0.000303	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALOX15—atherosclerosis	4.46e-05	0.000303	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	4.46e-05	0.000303	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	4.46e-05	0.000303	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCG5—atherosclerosis	4.41e-05	0.000299	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.4e-05	0.000299	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.34e-05	0.000295	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCG1—atherosclerosis	4.33e-05	0.000294	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LTA4H—atherosclerosis	4.27e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCG8—atherosclerosis	4.27e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LPA—atherosclerosis	4.26e-05	0.000289	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.22e-05	0.000286	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BGN—atherosclerosis	4.12e-05	0.00028	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOA5—atherosclerosis	4.08e-05	0.000277	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LCAT—atherosclerosis	4.07e-05	0.000277	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FABP4—atherosclerosis	4.07e-05	0.000277	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.04e-05	0.000275	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOA4—atherosclerosis	4e-05	0.000271	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.98e-05	0.00027	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP7A1—atherosclerosis	3.93e-05	0.000267	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	3.93e-05	0.000267	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLTP—atherosclerosis	3.8e-05	0.000258	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALOX5—atherosclerosis	3.79e-05	0.000258	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.74e-05	0.000254	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP27A1—atherosclerosis	3.63e-05	0.000247	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.58e-05	0.000243	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.55e-05	0.000241	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.49e-05	0.000237	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	3.44e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOA2—atherosclerosis	3.44e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	3.44e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALOX15—atherosclerosis	3.44e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NAMPT—atherosclerosis	3.4e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCG5—atherosclerosis	3.4e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.4e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LIPC—atherosclerosis	3.38e-05	0.00023	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCG1—atherosclerosis	3.38e-05	0.000229	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOC3—atherosclerosis	3.36e-05	0.000228	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LDLR—atherosclerosis	3.34e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.3e-05	0.000224	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.3e-05	0.000224	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LPA—atherosclerosis	3.28e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CETP—atherosclerosis	3.26e-05	0.000221	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BGN—atherosclerosis	3.18e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FABP4—atherosclerosis	3.17e-05	0.000215	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LCAT—atherosclerosis	3.17e-05	0.000215	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.16e-05	0.000214	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOA5—atherosclerosis	3.15e-05	0.000214	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SCARB1—atherosclerosis	3.12e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOA4—atherosclerosis	3.12e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP7A1—atherosclerosis	3.06e-05	0.000208	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.06e-05	0.000208	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	3.03e-05	0.000206	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3e-05	0.000203	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.97e-05	0.000202	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.96e-05	0.000201	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMGCR—atherosclerosis	2.95e-05	0.0002	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.93e-05	0.000199	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.92e-05	0.000198	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP27A1—atherosclerosis	2.83e-05	0.000192	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.79e-05	0.000189	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.72e-05	0.000184	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.7e-05	0.000184	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALOX15—atherosclerosis	2.68e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	2.68e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	2.68e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOA2—atherosclerosis	2.68e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCG5—atherosclerosis	2.65e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.65e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCA1—atherosclerosis	2.63e-05	0.000179	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.63e-05	0.000178	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.61e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LIPC—atherosclerosis	2.61e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.61e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOC3—atherosclerosis	2.59e-05	0.000176	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LDLR—atherosclerosis	2.58e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LPA—atherosclerosis	2.56e-05	0.000174	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CETP—atherosclerosis	2.52e-05	0.000171	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BGN—atherosclerosis	2.48e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.46e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOA5—atherosclerosis	2.45e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FABP4—atherosclerosis	2.45e-05	0.000166	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LCAT—atherosclerosis	2.45e-05	0.000166	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.41e-05	0.000164	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOA4—atherosclerosis	2.41e-05	0.000163	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.38e-05	0.000162	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.36e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	2.36e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.35e-05	0.000159	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.34e-05	0.000158	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.31e-05	0.000157	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.31e-05	0.000157	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALOX5—atherosclerosis	2.28e-05	0.000155	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMGCR—atherosclerosis	2.28e-05	0.000155	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMOX1—atherosclerosis	2.26e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.18e-05	0.000148	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOB—atherosclerosis	2.16e-05	0.000147	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.11e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—atherosclerosis	2.1e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.07e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOA2—atherosclerosis	2.07e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.07e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.07e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LPL—atherosclerosis	2.06e-05	0.00014	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.05e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.05e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.04e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.03e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LIPC—atherosclerosis	2.03e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCA1—atherosclerosis	2.03e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOC3—atherosclerosis	2.02e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPX1—atherosclerosis	2.01e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LDLR—atherosclerosis	2.01e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LPA—atherosclerosis	1.98e-05	0.000134	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CETP—atherosclerosis	1.96e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CD36—atherosclerosis	1.96e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BGN—atherosclerosis	1.91e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOA5—atherosclerosis	1.89e-05	0.000129	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.88e-05	0.000127	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.86e-05	0.000126	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.83e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARA—atherosclerosis	1.82e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.82e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.77e-05	0.00012	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AGT—atherosclerosis	1.77e-05	0.00012	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.76e-05	0.000119	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.74e-05	0.000118	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—atherosclerosis	1.73e-05	0.000117	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CAV1—atherosclerosis	1.71e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOA1—atherosclerosis	1.71e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOB—atherosclerosis	1.67e-05	0.000113	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.62e-05	0.00011	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.6e-05	0.000109	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LPL—atherosclerosis	1.59e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.58e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.58e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LIPC—atherosclerosis	1.57e-05	0.000106	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.56e-05	0.000106	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOC3—atherosclerosis	1.56e-05	0.000106	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPX1—atherosclerosis	1.55e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LDLR—atherosclerosis	1.55e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CETP—atherosclerosis	1.51e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CD36—atherosclerosis	1.51e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARG—atherosclerosis	1.51e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—INS—atherosclerosis	1.48e-05	0.0001	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.45e-05	9.84e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.43e-05	9.73e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARA—atherosclerosis	1.41e-05	9.55e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.37e-05	9.29e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AGT—atherosclerosis	1.36e-05	9.25e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.36e-05	9.21e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALB—atherosclerosis	1.35e-05	9.2e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—atherosclerosis	1.33e-05	9.06e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CAV1—atherosclerosis	1.32e-05	8.98e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOA1—atherosclerosis	1.32e-05	8.96e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOB—atherosclerosis	1.3e-05	8.82e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NOS3—atherosclerosis	1.3e-05	8.8e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.26e-05	8.58e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LPL—atherosclerosis	1.24e-05	8.42e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.22e-05	8.28e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPX1—atherosclerosis	1.21e-05	8.22e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.2e-05	8.18e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.19e-05	8.05e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CD36—atherosclerosis	1.18e-05	8e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARG—atherosclerosis	1.16e-05	7.89e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—INS—atherosclerosis	1.14e-05	7.74e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.12e-05	7.58e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARA—atherosclerosis	1.1e-05	7.44e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AGT—atherosclerosis	1.06e-05	7.2e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.05e-05	7.11e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALB—atherosclerosis	1.05e-05	7.09e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—atherosclerosis	1.04e-05	7.06e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CAV1—atherosclerosis	1.03e-05	6.99e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOA1—atherosclerosis	1.03e-05	6.98e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOB—atherosclerosis	1e-05	6.81e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NOS3—atherosclerosis	1e-05	6.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—atherosclerosis	9.75e-06	6.62e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LPL—atherosclerosis	9.57e-06	6.5e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CG—atherosclerosis	9.39e-06	6.37e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPX1—atherosclerosis	9.34e-06	6.34e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—atherosclerosis	9.14e-06	6.21e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CD36—atherosclerosis	9.1e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARG—atherosclerosis	9.06e-06	6.15e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—INS—atherosclerosis	8.88e-06	6.03e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTHFR—atherosclerosis	8.62e-06	5.85e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARA—atherosclerosis	8.46e-06	5.74e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AGT—atherosclerosis	8.19e-06	5.56e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALB—atherosclerosis	8.14e-06	5.53e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—atherosclerosis	8.03e-06	5.45e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CAV1—atherosclerosis	7.95e-06	5.4e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOA1—atherosclerosis	7.93e-06	5.39e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NOS3—atherosclerosis	7.79e-06	5.29e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	7.24e-06	4.92e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—atherosclerosis	7.13e-06	4.84e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARG—atherosclerosis	6.99e-06	4.74e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—INS—atherosclerosis	6.86e-06	4.65e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALB—atherosclerosis	6.29e-06	4.27e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NOS3—atherosclerosis	6.01e-06	4.08e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AKT1—atherosclerosis	5.96e-06	4.04e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—atherosclerosis	5.5e-06	3.73e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AKT1—atherosclerosis	4.6e-06	3.12e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AKT1—atherosclerosis	3.58e-06	2.43e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AKT1—atherosclerosis	2.76e-06	1.88e-05	CbGpPWpGaD
